Recent Material Events - Keryx Biopharmaceuticals, Inc (KERX)

Filing Date	Description
2008-06-06	(b) On June 5, 2008, Beth F. Levine, Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary of Keryx Biopharmaceuticals, Inc. (the “Company”), submitted her resignation to the Company. The r ...
2008-03-14	(b) As a result of cost-cutting initiatives resulting from the recent clinical failure of Sulonex (sulodexide), Keryx Biopharmaceuticals, Inc. (the “Company”) and its Chief Accounting Officer, Mark Stier, have mutually agree ...
2008-03-10	On March 7, 2008, Keryx Biopharmaceuticals, Inc. (the “Company”) issued a press release announcing top-line results from its SUN-MICRO Phase 3 clinical trial of Sulonex (sulodexide) for the treatment of diabetic nephropathy . A cop ...
2008-02-22	On February 22, 2008, Keryx Biopharmaceuticals, Inc. (“Keryx”) issued a press release announcing results of operations for the fourth quarter and year ended December 31, 2007. Keryx also announced that on Monday, February 25, 2008, at ...
2007-03-08	On March 8, 2007, Keryx Biopharmaceuticals, Inc. (“Keryx”) issued a press release announcing results of operations for the fourth quarter and year ended December 31, 2006. Keryx also announced that it would host a conference call on M... ...
2007-02-12	On February 9, 2007, the Compensation Committee of the Board of Directors of Keryx Biopharmaceuticals, Inc. (the “Compensation Committee”) approved annual base salaries for fiscal year 2007 for its named executive officers, as s... ...
2006-11-08	(b) On November 7, 2006, Dr. Lindsay A. Rosenwald resigned as a member of the Board of Directors (the “Board”) of Keryx Biopharmaceuticals, Inc. (“Keryx”) in order to devote more time to his other professional and personal... ...
2006-11-01	On November 1, 2006, Keryx Biopharmaceuticals, Inc. (“Keryx”) issued a press release announcing results of operations for the third quarter ended September 30, 2006, and announced that it would host a conference call on November 2, 20... ...
2006-10-04	On October 4, 2006, Keryx Biopharmaceuticals, Inc. (“Keryx”) issued a press release announcing that Keryx entered into an exclusive licensing agreement (the "Agreement") with Kyowa Hakko Kogyo Co., Ltd. (“Kyowa”), a Tokyo-b... ...